CHAL 10 - Pharmaceutical patent litigation

被引：0

作者：

Ahmed, Ali I. ^{[1
]}

机构：

[1] Finnegan Henderson Farabow Garrett & Dunner LLP, Washington, DC 20001 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 237卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

10-CHAL

引用

页码：949 / 949

页数：1

共 50 条

[31] CHAL 1-US patent legislation
Fleischut, Paul
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
[32] VIEW ON PATENT LITIGATION AND ON PATENT SYSTEM
WRIGHT, CM
[J]. JOURNAL OF THE PATENT OFFICE SOCIETY, 1977, 59 (07): : 409 - 423
[33] CHAL 4-Careers in patent information
Burcham, Sandy
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[34] CHAL 19-Patent Law 101
Bunker, Jared
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[35] The patent litigation protocol and the community patent
Pagenberg, J
[J]. IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW, 2003, 34 (05): : 535 - 539
[36] CHAL 3-Academic patent law
Seymore, Sean B.
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[37] CHAL 5-Maximizing patent protection in a chemical patent application
Thompson, Sandra
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[38] Korea: the new first battleground for the high stakes poker game of pharmaceutical patent litigation
Choe, Jeong Yeol
Yoon, Kyung Ae
Lee, Samuel
[J]. PHARMACEUTICAL PATENT ANALYST, 2015, 4 (06) : 409 - 413
[39] THE STAY DILEMMA: EXAMINING BRAND AND GENERIC INCENTIVES FOR DELAYING THE RESOLUTION OF PHARMACEUTICAL PATENT LITIGATION
Herman, Michael R.
[J]. COLUMBIA LAW REVIEW, 2011, 111 (08) : 1788 - 1832
[40] Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson, JD
Mehr, Stanton R.
Nelson, Kevin M.
[J]. AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (01): : 23 - 26

← 1 2 3 4 5 →